Drugmakers raised prices on hundreds of drugs despite Trump deals, report finds

A report found that drugmakers increased prices on hundreds of drugs despite President Trump's TrumpRx initiative aimed at reducing costs. Trump had announced the program in February 2020, but the analysis revealed ongoing price hikes by pharmaceutical companies.